Influence of biologically active substance Darmonal and phytin compounds on the liver functional state at experimental hepatitis caused by paracetamol

The study aimed to investigate the protective mechanisms of substance Darmonal and phytin compounds in the experimental model of acute toxic drug-induced hepatitis caused by paracetamol in rats. The material and methods The research was carried out on white outbred rats of both sexes weighing 140-200 g. Drug-induced liver damage was reproduced by introduction of paracetamol into the stomach in dose 500 mg/kg for 2 days. The test compounds Darmonal, Fitin-C and reference drug Liv.52 were administered for 7 days after hepatitis reproduction in doses 100 mg/kg. The effectiveness and mechanism of action for selected supramolecular complexes in the model of toxic drug-induced hepatitis was made by paracetamol. It was researched that liver protein-synthesizing function was due to the content of total protein and albumin in the blood serum, the excretory and toxic function of the liver by the content of total and direct bilirubin as well as the endogenous intoxication were according to the content of urea in the blood serum, but cytolytic syndrome occurred because of the activity of indicator enzymes (alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in blood serum). Research results. The study of specific activity of Darmonal in combination with Fitin-C and the reference drug Liv.52 on the model of paracetamol and carbon tetrachloride hepatitis showed that the drugs, being administered in dose 100 mg/kg, had a pronounced hepatoprotective effect.

Darmonal substance, Darmonal A, Liv.52, paracetamol toxic hepatitis alanine aminotransferases, aspartate aminotransferases, gamma-glutamil transferases, alkaline phosphatase

1. Mironov A. N. Guidelines for the study of hepatoprotective activity of drugs. In Guidelines for conducting preclinical studies of drugs. Moscow. 2012, 944 P. (in Russ.)@@ Методические рекомендации по изучению гепатопротективной активности лекарственных средств. С. 710-718 /Руководство по проведению доклинических исследований лекарственных средств. Часть первая //Под ред. Миронова А. Н. - М.-2012 - с. 944.

2. Nabiev A.N., Tulyaganov R. T., Vakhabov A. A. Guidelines for the experimental study of new pharmacological substances with choleretic and hepatoprotective activity. Tashkent. MH RUz Publ., 2007, 27P. (in Russ.)@@ Методические рекомендации по экспериментальному изучению новых фармакологических веществ с желчегонной и гепатопротекторной активностью // Авт. Набиев А. Н., Туляганов Р. Т., Вахабов А. А. МЗ РУз Ташкент - 2007, - С. 27

3. Strelkov, R.B. [Statistical tables for accelerated assessment of the pharmacological effect]. Pharmacology and toxicology. 1986;(4):100-104. (in Russ.)@@ Стрелков, Р. Б. Статистические таблицы для ускоренной оценки фармакологического эффекта / Р. Б. Стрелков // Фармакология и токсикология. -1986. № 4. -С. 100-104.

4. Karimova G.A., Aminov S. D., Dusmurodova F. X. Effect of darmonal and phytin complex compounds on carbohydrates metabolism at experimental toxic hepatitis. Yevrosiyo pediatriya Axborotnomasi. 2022;1(12):82-86. (in Russ.)@@ Каримова Г. А., Аминов С. Д., Дусмуродова Ф. Х. Влияние дармонала и комплексных соединений фитина на углеводный обмен при экспериментальном токсическом гепатите. Евразийский вестник педиатрии. 2022. - № 1(12). - С. 82-86.